Thursday 19 September 34 sessions
Friday 20 September 30 sessions
Saturday 21 September 32 sessions
Dr Carla Moran
Carla Moran
MTE2.1
Thu 19 14:45 MEET THE EXPERT 2.1
The interpretation of abnormal thyroid function tests in children and adolescents
Dr Carla Moran
Carla Moran
MTE2.2
Sat 21 08:00 MEET THE EXPERT 2.2
The interpretation of abnormal thyroid function tests in children and adolescents
John Achermann
John Achermann
S7.2
Fri 20 14:30 SYMPOSIUM 7 - New Horizens in the Management in Adrenal Insufficiency
Novel insights into the pathophysiology of adrenal insufficiency syndromes
Karine Rizzoti
Karine Rizzoti
NA1
Fri 20 17:00 NOVEL ADVANCES 1
Single Cell technologies
Irina-Alexandra Bacila
Irina-Alexandra Bacila
RFC13.2
Sat 21 09:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 13 - Adrenals and HP axis
Development of novel non-invasive strategies for monitoring of treatment control in patients with congenital adrenal hyperplasia
Hoong-Wei Gan
Hoong-Wei Gan
RFC11.1
Sat 21 09:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 11 - Pituitary, neuroendocrinology and metabolism Session 2
National United Kingdom evidence- and consensus-based guidelines for the investigation, treatment and long-term follow-up of paediatric craniopharyngioma
Sumana Chatterjee
Sumana Chatterjee
RFC14.4
Sat 21 09:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 14 - GH and IGF1
GHR transcript heterogeneity may explain the phenotypic variability in patients with homozygous GHR pseudoexon (6Ψ) mutation
Avinaash Maharaj
Avinaash Maharaj
FC13.5
Sat 21 09:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 13 - Adrenals and HP axis
SGPL1 deficiency leads to downregulation of key enzymes within the steroidogenic pathway
Suma Uday
Suma Uday
RFC6.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Evaluating genotype–phenotype correlation using an in vitro mutagenesis model in bi-allelic mutations resulting in extreme hypophosphatasia clinical phenotypes
Tim Cheetham
Tim Cheetham
MTE7.2
Sat 21 14:00 MEET THE EXPERT 7.2
Management of Graves disease
Ram Weiss
Ram Weiss
WG2.1
Thu 19 08:00 ESPE Obesity Working Group (OWG)
Pathogenesis of Insulin Resistance
Tetyana Chaychenko
Tetyana Chaychenko
WG2.2
Thu 19 08:00 ESPE Obesity Working Group (OWG)
EU vs. non-EU practices on Insulin Resistance assessment (ESPE ObWG project)
Claude Marcus
Claude Marcus
WG2.3
Thu 19 08:00 ESPE Obesity Working Group (OWG)
Insulin function in obese children within the low and high ranges of impaired fasting glycemia
Reinhard Holl
Reinhard Holl
WG2.4
Thu 19 08:00 ESPE Obesity Working Group (OWG)
Adolescent type 2 diabetes: Comparing prospective registries
Thomas Reinehr
Thomas Reinehr
WG2.5
Thu 19 08:00 ESPE Obesity Working Group (OWG)
Youth onset T2D (2018 ISPAD Consensus Guidelines)
Thomas Reinehr
Thomas Reinehr
WG5.3
Thu 19 08:00 ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG)
Lifestyle intervention in PCOS
Christa Flück
Christa Flück
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Introduction
Christa Flück
Christa Flück
YB2.1
Fri 20 08:30 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 2
DSD and gender dysphoria
Nadine Hornig
Nadine Hornig
WG1.1
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Epigenetics and the androgen insensitivity syndrome
Nuria Camats
Nuria Camats
WG1.2
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Oligogenic origin of DSD
Lloyd Tack
Lloyd Tack
WG1.3
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Postpubertal outcome of boys born with hypospadias
Lloyd Tack
Lloyd Tack
RFC8.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Growth, pubertal course and long-term outcome of 46,XY boys born with atypical genitalia and low birthweight
Jürg Streuli
Jürg Streuli
WG1.4
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Shared or Shaped Decision-Making in DSD
DSD discussion
DSD discussion
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Discussion with attendees
Tülay Güran
Tülay Güran
Thu 19 08:00 ESPE Working Group on Disorders of Sex Development (DSD)
Conclusion
Adalbert Raiman
Adalbert Raiman
WG3.1
Thu 19 08:00 ESPE Working Group on Bone and Growth Plate (BGP)
Lethal pyridoxin-independent encephalopathy in a case of perinatal hypophosphatasia
Saygin Abali
Saygin Abali
WG3.2
Thu 19 08:00 ESPE Working Group on Bone and Growth Plate (BGP)
Congenital talipes equinovarus and bowing of femur due to homozygous TRPV6 mutation
Frank Rutsch
Frank Rutsch
WG3.3
Thu 19 08:00 ESPE Working Group on Bone and Growth Plate (BGP)
Mechanisms of vascular calcification and potential treatment implications
Klaus Mohnike
Klaus Mohnike
WG3.4
Thu 19 08:00 ESPE Working Group on Bone and Growth Plate (BGP)
Update on BOND
Katherine Staines
Katherine Staines
WG3.5
Thu 19 08:00 ESPE Working Group on Bone and Growth Plate (BGP)
New insights in growth plate fusion
Moshe Phillip
Moshe Phillip
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
Introduction
Jacques Beltrand
Jacques Beltrand
WG4.1
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
Impact of hypoglycemia on cognitive function
Jasna Omladič
Jasna Omladič
WG4.2
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
Impact of hyperglycemia on cognitive function
Urakami Tatsuhiko
Urakami Tatsuhiko
WG4.3
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
Type 2 diabetes and the brain
Michal Nevo
Michal Nevo
WG4.4
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
Fear of hyperglycemia
Tadej Battelino
Tadej Battelino
WG4.5
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
Time in Range (TIR) - Highlights from the consensus meeting February 2019
Boris Kovatchev
Boris Kovatchev
WG4.6
Thu 19 08:00 ESPE Working Group on Diabetes Technology (DT)
How technology helps to improve TIR (open and closed loop)
Francis Zegher
Francis Zegher
WG5.1
Thu 19 08:00 ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG)
Early Origins of PCOS 
Lourdes Ibáñez
Lourdes Ibáñez
WG5.2
Thu 19 08:00 ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG)
Diagnosis & pharmacological intervention in PCOS
Angelica Hirschberg
Angelica Hirschberg
WG5.4
Thu 19 08:00 ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG)
Androgen Excess in female athletes 
Kathy Hoeger
Kathy Hoeger
WG5.5
Thu 19 08:00 ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG)
Contraception in adolescence
Annelou Vries
Annelou Vries
WG6.1
Thu 19 08:00 ESPE Working Group on Gender Dysphoria (GD)
Assessing competence to consent to physical treatment in transgender adolescents
Annelou Vries
Annelou Vries
S6.2
Fri 20 14:30 SYMPOSIUM 6
Psychiatric comorbidities in Transgender Youth
Mark-Bram Bouman
Mark-Bram Bouman
WG6.2
Thu 19 08:00 ESPE Working Group on Gender Dysphoria (GD)
Surgical options for the transfemale
Nim Christopher
Nim Christopher
WG6.3
Thu 19 08:00 ESPE Working Group on Gender Dysphoria (GD)
Surgical options for the transmale
Malcolm Donaldson
Malcolm Donaldson
WG7.1
Thu 19 08:00 ESPE Working Group on Turner Syndrome (TS)
Oral versus transdermal induction of puberty - The Turner Working Group of ESPE proposal
Malcolm Donaldson
Malcolm Donaldson
FC9.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Iodine status of pregnant women and their newborns in the UK – the MABY study
Berit Kristrom
Berit Kristrom
WG7.2
Thu 19 08:00 ESPE Working Group on Turner Syndrome (TS)
Theoretical and practical implications of transdermal approach to pubertal induction
Melanie Davis
Melanie Davis
WG7.3
Thu 19 08:00 ESPE Working Group on Turner Syndrome (TS)
Endocrine management of Turner Syndrome in adolescents and early adulthood
Kathrin Fleischer
Kathrin Fleischer
WG7.4
Thu 19 08:00 ESPE Working Group on Turner Syndrome (TS)
Fertility preservation- technical and ethical aspects
Anthonie Duijnhouwers
Anthonie Duijnhouwers
WG7.5
Thu 19 08:00 ESPE Working Group on Turner Syndrome (TS)
Cardiac morbidity and mortality during pregnancy in TS
Josef Penninger
Josef Penninger
PL1
Thu 19 10:45 PLENARY 1 - RANKL and RANK: Bone and Beyond
RANKL and RANK: Bone and beyond
Antje Körner
Antje Körner
S1.1
Thu 19 12:00 SYMPOSIUM 1
Off the weight curve – dynamics of childhood obesity
Frank Scott
Frank Scott
S1.2
Thu 19 12:00 SYMPOSIUM 1
The gut microbiome and Obesity
Christine Poitou
Christine Poitou
S1.3
Thu 19 12:00 SYMPOSIUM 1
New developments for treatments in monogenic disorders focusing on setmelanotide trials
Jeffrey Baron
Jeffrey Baron
S2.1
Thu 19 12:00 SYMPOSIUM 2
Longitudinal bone growth: fundamental mechanisms to clinical applications
Frank Rauch
Frank Rauch
S2.2
Thu 19 12:00 SYMPOSIUM 2
Anabolic therapies for osteoporosis in childhood
Leanne Ward
Leanne Ward
S2.3
Thu 19 12:00 SYMPOSIUM 2
Steroid-Associated Osteoporosis in the Pediatric Population
Anu Bashamboo
Anu Bashamboo
S3.1
Thu 19 12:00 SYMPOSIUM 3
Genetics of DSD – do we understand it?
Anna Nordenström
Anna Nordenström
S3.2
Thu 19 12:00 SYMPOSIUM 3
Outcomes in DSD – insight from the DSD life study
Andy Greenfield
Andy Greenfield
S3.3
Thu 19 12:00 SYMPOSIUM 3
Novel insights into sex determination
David Maahs
David Maahs
S4.1
Thu 19 12:00 SYMPOSIUM 4
Hypoglycemia in children with T1D: Past, Present, and Future
Kim Donaghue
Kim Donaghue
S4.2
Thu 19 12:00 SYMPOSIUM 4
Novel advances in diabetic retinopathy screening and management
Loredana Marcovecchio
Loredana Marcovecchio
S4.3
Thu 19 12:00 SYMPOSIUM 4
Prediction of renal and cardiovascular complications
Martine Cools
Martine Cools
MTE1.1
Thu 19 14:45 MEET THE EXPERT 1.1
Holistic approach to the individual with DSD
Martine Cools
Martine Cools
MTE1.2
Fri 20 08:30 MEET THE EXPERT 1.2
Holistic approach to the individual with DSD
Mariacarolina Salerno
Mariacarolina Salerno
HDI1.1
Thu 19 14:45 HOW DO I...
How Do I... Manage subclinical hypothyroidism
Maithé Tauber
Maithé Tauber
HDI1.2
Thu 19 14:45 HOW DO I...
How Do I... Manage a patient with Prader Willi and GH at transition - do they benefit as adults?
Francesco Chiarelli
Francesco Chiarelli
HDI1.3
Thu 19 14:45 HOW DO I...
How do I... Manage a child with insulin resistance
Wolfgang Högler
Wolfgang Högler
RFC2.1
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Burosumab resulted in better clinical outcomes than continuation with conventional therapy in both younger (1-4 years-old) and older (5-12 years-old) children with X-linked hypophosphatemia
Julia André
Julia André
RFC2.2
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Does the treatment with recombinant human growth hormone improve final height in patients affected by X-linked hypophosphatemia?
David Martin
David Martin
RFC2.3
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Growth hormone effects on metacarpal bone geometry and bone age in growth hormone-deficient children
David Martin
David Martin
FC2.6
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Validation of a new version of BoneXpert bone age in children with congenital adrenal hyperplasia (CAH), precocious puberty (PP), growth hormone deficiency (GHD), Turner syndrome (TS), and other short stature diagnoses
Natascia Lorgi
Natascia Lorgi
RFC2.4
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Bone mass and fracture prevalence in childhood brain cancer survivors 2, 5 or 7 years after off therapy
Theo Sas
Theo Sas
RFC2.5
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Long term effects of treatment with oxandrolone (Ox) in addition to growth hormone (GH) in girls with Turner syndrome (TS) on bone mineral density in adulthood
Andreas Kyriakou
Andreas Kyriakou
RFC2.6
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Impact of pubertal suppression on body composition and bone mineral density in adolescents with gender dysphoria
Agnès Linglart
Agnès Linglart
FC2.1
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Continued improvement in clinical outcomes with burosumab, a fully human anti-FGF23 monoclonal antibody: results from a 3-year, phase 2, clinical trial in children with X-linked hypophosphatemia (XLH)
Annemieke Boot
Annemieke Boot
FC2.2
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Benefits of long-term burosumab persist in 11 girls with X-linked hypophosphatemia (XLH) who transitioned into adolescence during the phase 2 CL201 trial
Volha Zhukouskaya
Volha Zhukouskaya
FC2.3
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Higher dose of burosumab is needed for treatment of children with severe forms of X linked hypophosphatemia
Adalbert Raimann
Adalbert Raimann
FC2.4
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
New imaging approaches to the quantification of musculoskeletal alterations in X-linked hypophosphatemic rickets (XLH)
Adalbert Raimann
Adalbert Raimann
RFC15.5
Sat 21 09:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 15 - Late Breaking Session
De novo missense mutation in SP7 in a patient with cranial hyperostosis, long bone fragility, and increased osteoblast number
Huda Elsharkasi
Huda Elsharkasi
FC2.5
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 2 - Bone, growth plate and mineral metabolism Session 1
Age and gender-specific reference data for high-resolution magnetic resonance based musculoskeletal parameters in healthy children and young people
Salma Ali
Salma Ali
RFC3.1
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
European Registries For Rare Endocrine Conditions (EuRRECa): results from the pilot phase of The Platform For e-Reporting Of Rare Endocrine Conditions (e-REC)
Laura Atger-Lallier
Laura Atger-Lallier
RFC3.2
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Factors affecting loss to follow-up for patients with chronic endocrine conditions during the pediatric period: a cohort study at a reference center for rare diseases
Maha Abdulhadi-Atwan
Maha Abdulhadi-Atwan
RFC3.3
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
The founder homozygous NR5A1 gene mutation p.R103Q causes asplenia and severe XY-DSD and XX-DSD in a Palestinian cohort
Shuji Sai
Shuji Sai
RFC3.4
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Peripheral glucocorticoid metabolism may reflect resolution of inflammation in Kawasaki disease
Patrizia Bruzzi
Patrizia Bruzzi
RFC3.5
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Evaluation of endothelial function in childhood standard risk acute lymphoblastic leukemia survivors: role of subclinical markers and identification of preventable factors
Primož Kotnik
Primož Kotnik
RFC3.6
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Prevalence of endocrine complications in Duchenne muscular dystrophy
Maki Fukami
Maki Fukami
FC3.1
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Germline-derived gain-of-function variants of Gsα-coding GNAS gene identified in nephrogenic syndrome of inappropriate antidiuresis: the first report
Francesca Cirillo
Francesca Cirillo
FC3.2
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
CFTR loss-of-function has effects on microRNAs (miRNAs) that regulate genes involved in growth, glucose metabolism and in fertility in in vitro models of cystic fibrosis
Maria Velazquez
Maria Velazquez
FC3.3
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Variability in drug metabolizing cytochrome P450 activities caused by human genetic variations in NADPH cytochrome P450 oxidoreductase (POR)
Satoshi Watanabe
Satoshi Watanabe
FC3.4
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Droplet digital PCR is a useful method for detection of mosaic mutations in patients with McCune–Albright syndrome
Samantha Lee
Samantha Lee
FC3.5
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Evaluation of endocrine late effects in survivors of childhood allogeneic hematopoietic stem cell transplantation in Australia database from 1985 to 2011
Joonatan Borchers
Joonatan Borchers
FC3.6
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 3 - Multi-system endocrine disorders
Severe infections contribute to increased risk of early death in patients with apeced
Kikumi Ushijima
Kikumi Ushijima
RFC1.1
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Low prevalence of maternal microchimerism in Japanese children with type 1 diabetes
Zhou Pei
Zhou Pei
RFC1.2
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Gabra5 contributes to sexual dimorphism in POMC neural activity and glucose metabolism
Jose Morales
Jose Morales
RFC1.3
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
The association between IGF-1 levels and nonalcoholic fatty liver disease (NAFLD) in adolescents with type 2 diabetes
Luis Salamanca
Luis Salamanca
RFC1.4
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Estimation of MODY frequency and prevalent subtypes in pediatric patients by targeted NGS
Caiqi Du
Caiqi Du
RFC1.5
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Decreased circulating levels of MOTS-c in individuals with newly diagnosed type 1 diabetes children
Nancy Elbarbary
Nancy Elbarbary
RFC1.6
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
An oral trace element supplementation has a potential beneficial effect on glucose homeostasis in transfused patients with β-thalassemia major complicated with diabetes mellitus
Hong Chen
Hong Chen
FC1.1
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Insulin resistance leads to mitochondrial dysfunction in hepatocyte
Kyung-Mi Jang
Kyung-Mi Jang
FC1.2
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Three new genes (PTPRD, SYT9, and WSF1) related to Korean maturity-onset diabetes in the young (MODY) children decrease insulin synthesis and secretion in human pancreatic beta cells
Amalia Sertedaki
Amalia Sertedaki
FC1.3
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
Next generation sequencing in Greek MODY patients increases diagnostic accuracy and reveals a high percentage of MODY12 cases
Georgina Williams
Georgina Williams
FC1.5
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
FADES: A birth cohort to understand the mechanisms underlying accelerated onset of autoimmunity in children with Down’s syndrome
Noah Gruber
Noah Gruber
FC1.6
Thu 19 14:45 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 1 - Diabetes and Insulin Session 1
A novel biochemical marker, fatty acid-binding protein 4, in diabetic ketoacidosis in children
Russell Foster
Russell Foster
PL2
Thu 19 16:30 PLENARY 2
Light, Body Clocks and Sleep: Biology to New Therapeutics
Claus Gravholt
Claus Gravholt
MTE3.1
Thu 19 17:00 MEET THE EXPERT 3.1
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus Gravholt
Claus Gravholt
MTE3.2
Sat 21 08:00 MEET THE EXPERT 3.2
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International
Julia Rohayem
Julia Rohayem
MTE4.1
Thu 19 17:00 MEET THE EXPERT 4.1
Klinefelter syndrome - when should testosterone be started
Julia Rohayem
Julia Rohayem
MTE4.2
Sat 21 08:00 MEET THE EXPERT 4.2
Klinefelter syndrome - when should testosterone be started
Evangelia Charmandari
Evangelia Charmandari
YB1.1
Thu 19 17:00 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 1
Adrenals
Evangelia Charmandari
Evangelia Charmandari
Fri 20 12:30 ESPE AWARDS
ESPE International Outstanding Clinician Award
Evangelia Charmandari
Evangelia Charmandari
Fri 20 12:30 ESPE AWARDS
Outstanding Clinician Award
Khalid Hussain
Khalid Hussain
YB1.2
Thu 19 17:00 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 1
Antenatal and Neonatal Endocrinology
Ola Nilsson
Ola Nilsson
YB1.3
Thu 19 17:00 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 1
Bone, Growth Plate and Mineral Metabolism
Orit Pinhas-Hamiel
Orit Pinhas-Hamiel
YB1.4
Thu 19 17:00 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 1
Type 2 Diabetes, Metabolic Syndrome and Lipids
Ken Ong
Ken Ong
YB1.5
Thu 19 17:00 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 1
Editor's Choice
Giorgia Pepe
Giorgia Pepe
RFC5.1
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Hurthle cell carcinoma in childhood retrospective analysis of a large series
Marek Niedziela
Marek Niedziela
RFC5.2
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Ultrasound features of multinodular goiter in DICER1 syndrome
Alexander Anikiev
Alexander Anikiev
RFC5.3
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Experience of thyroid surgery in children with intraoperative neuromonitoring
Sommayya Aftab
Sommayya Aftab
RFC5.4
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Thyroid dysfunction in patients following thymus transplantation in a tertiary centre: a 10-year experience
Sommayya Aftab
Sommayya Aftab
RFC9.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1
Eve Stern
Eve Stern
RFC5.5
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
A novel mutation in the thyroglobulin gene leading to neonatal goiter and congenital hypothyroidism in an Eritrean infant
Fang Yanlan
Fang Yanlan
RFC5.6
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Complex single nucleotide polymorphisms in SEPINA 7 lead to TBG deficiency
Claire Wood
Claire Wood
FC5.1
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Randomised trial of block and replace versus dose titration antithyroid drug treatment in children and adolescents with thyrotoxicosis
Karolina Stożek
Karolina Stożek
FC5.2
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Lower proportion of CD19+IL-10+ and CD19+CD24hiCD27+ IL-10+, but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases
Young Lee
Young Lee
FC5.3
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Predominant DICER1 mutations in pediatric follicular thyroid carcinomas
Stéphanie Larrivée-Vanier
Stéphanie Larrivée-Vanier
FC5.4
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Thyroid dysgenesis: exome-wide analysis identifies rare variants in genes involved in thyroid development and cancer
Daniela Choukair
Daniela Choukair
FC5.5
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Identification of TRPC4AP as a novel candidate gene causing thyroid dysgenesis
Atsushi Suzuki
Atsushi Suzuki
FC5.6
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 5 - Thyroid
Homozygous loss-of-function mutation in the SLC26A7 gene coding a novel iodide transporter causes goitrous congenital hypothyroidism
Junfen Fu
Junfen Fu
RFC4.1
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Expression of miRNAs in circulating exosomes derived from patients with NAFLD
Xuelian Zhou
Xuelian Zhou
RFC4.2
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Circulating exosomal miRNAs in children’s nonalcoholic steatohepatitis and the correlation with serum transaminase and uric acid
Judit Bassols
Judit Bassols
RFC4.3
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Dysregulated gene expression profile in visceral adipose tissue of juvenile Wistar rats with catch-up growth: association with fat expansion and metabolic parameters
Judit Bassols
Judit Bassols
FC9.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
DNA methylation signatures in placenta and umbilical cord: association with maternal obesity
Anna Kirstein
Anna Kirstein
RFC4.4
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
The novel phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib effectively inhibits growth of PTEN haploinsufficient lipoma cells
Feihong Luo
Feihong Luo
RFC4.5
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
GDF5 increased white adipose tissue thermogenesis through p38 MAPK signaling pathway in fatty acid-binding protein 4-GDF5 transgenic mice
Christian Roth
Christian Roth
RFC4.6
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Appetite suppressing effects of glucoregulatory peptides devoid of nausea
Christian Roth
Christian Roth
FC4.6
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Brain satiety responses to a meal in children before and after weight management intervention
Mitra Nourbakhsh
Mitra Nourbakhsh
FC4.1
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Involvement of visfatin in adipose tissue fibrosis through modulation of extracellular matrix proteins
Martha Hanschkow
Martha Hanschkow
FC4.2
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Characterization of the adipose progenitor cell marker MSCA1 in normal weight and obese children
Marta Díaz
Marta Díaz
FC4.3
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal size
Anna Sessa
Anna Sessa
FC4.4
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
The rs72613567:TA variant in the hydroxysteroid 17-beta dehydrogenase 13 gene reduces liver damage in obese children
Omneya Omar
Omneya Omar
FC4.5
Thu 19 17:00 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 4 - Fat, metabolism and obesity
Leptin gene methylation status in Egyptian infants
Daniele Tessaris
Daniele Tessaris
MTE5.1
Fri 20 08:30 MEET THE EXPERT 5.1
Managing endocrinopathies in McCune-Albright Syndrome
Daniele Tessaris
Daniele Tessaris
MTE5.2
Sat 21 08:00 MEET THE EXPERT 5.2
Managing endocrinopathies in McCune-Albright Syndrome
Zdenek Sumnik
Zdenek Sumnik
MTE6.1
Fri 20 08:30 MEET THE EXPERT 6.1
Management of Diabetic Ketoacidosis
Zdenek Sumnik
Zdenek Sumnik
MTE6.2
Sat 21 14:00 MEET THE EXPERT 6.2
Management of Diabetic Ketoacidosis
Klaus Monicke
Klaus Monicke
MTE8.1
Fri 20 08:30 MEET THE EXPERT 8.1
Management of neonatal hypoglycaemia
Klaus Monicke
Klaus Monicke
MTE8.2
Sat 21 14:00 MEET THE EXPERT 8.2
Management of neonatal hypoglycaemia
Danilo Fintini
Danilo Fintini
YB2.2
Fri 20 08:30 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 2
Growth and Growth Factors
Martin Wabitsch
Martin Wabitsch
YB2.3
Fri 20 08:30 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 2
Obesity and Weight Regulation
Carla Bizzarri
Carla Bizzarri
YB2.4
Fri 20 08:30 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 2
Oncology and Chronic Disease
Jean-Pierre Chanoine
Jean-Pierre Chanoine
YB2.5
Fri 20 08:30 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 2
Global Health for the Paediatric Endocrinologist
Jean-Pierre Chanoine
Jean-Pierre Chanoine
Fri 20 14:00 Global Pediatric Endocrinology and Diabetes (GPED) - The Long Winding Road towards Sustainable Access to Affordable Insulin
Introduction
Jing Wu
Jing Wu
RFC6.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
EFTUD2 gene deficiency disturbs maturation of osteoblast and inhibits chondrocyte differentiation via activated p53 signaling
Maria Faienza
Maria Faienza
RFC6.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
High levels of LIGHT/TNFSF14 in Prader–Willi syndrome
Despoina Manousaki
Despoina Manousaki
RFC6.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Increased burden of common risk alleles in children with a significant fracture history
Aysun Ata
Aysun Ata
RFC6.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Targeted molecular genetic diagnosis by next generation sequence analysis method and investigation of responsible candidate genes in patients with osteogenesis imperfecta
Jan Lebl
Jan Lebl
RFC6.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Genetic aetiology predicts growth hormone (GH) treatment outcomes in children born small-for-gestational-age with persistent short stature (SGA-SS). Lessons from a single-centre cohort
Ghazal Hedjazi
Ghazal Hedjazi
FC6.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Bone tissue characterization of a mouse model of atypical type VI osteogenesis imperfecta reveals hypermineralization of the bone matrix, elevated osteocyte lacunar density and altered vascularity
Alireza Javanmardi
Alireza Javanmardi
FC6.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Zone wise cell separation methods comparison, based on relative expression of specific growth plate markers in a pig model
Ondrej Soucek
Ondrej Soucek
FC6.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Decreased trabecular bone mineral density and muscle area at the forearm despite improvement in glycaemic control over 3 years after simultaneous pancreas kidney transplantation
Elif Ozsu
Elif Ozsu
FC6.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Metabolically unhealthy obese children and adolescents have higher bone mineral density than normal weighted controls but lower than metabolically healthy obeses: no effect of FGF21 levels
Roland Schweizer
Roland Schweizer
FC6.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
No change in bone density during 6 months off GH in adolescents with severe GHD at near-adult height
Isolina Riaño-Galan
Isolina Riaño-Galan
FC6.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 6 - Bone, growth plate and mineral metabolism Session 2
Craniosynostosis in inactivating PTH/PTHrP signaling disorder 2: a non-classical feature to consider
Sarah Ehtisham
Sarah Ehtisham
RFC7.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Accuracy of glucose sensor estimate of HbA1c in children with type 1 diabetes
Christian Denzer
Christian Denzer
RFC7.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
β-cell function and glucose effectiveness in the development of impaired fasting glucose in obese European children and adolescents
Amany Ibrahim
Amany Ibrahim
RFC7.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Osteopontin as an early urinary marker of diabetic nephropathy in adolescents with type 1 diabetes mellitus
Hae Jung
Hae Jung
RFC7.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Handgrip strength correlates with insulin resistance and the metabolic syndrome in children and adolescents: analysis of the Korean National Health and Nutrition Examination Survey 2014-2016
Kineret Mazor-Aronovitch
Kineret Mazor-Aronovitch
RFC7.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Dual diagnosis of type 1 diabetes and ADHD
Barbara Predieri
Barbara Predieri
RFC7.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Health-related quality of life and diabetes control in immigrant and Italian children and adolescents with type 1 diabetes and in their parents
Eleni Kotanidou
Eleni Kotanidou
FC7.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Deployment of a predictive model based on CpG methylation haplotypes analysis on the insulin gene promoter, in a cohort of children and adolescents with type 1 diabetes
Gabor Szinnai
Gabor Szinnai
FC7.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Copeptin kinetics and its relationship to osmolality during rehydration for diabetic ketoacidosis in children: an observational study
Gabor Szinnai
Gabor Szinnai
YB3.3
Sat 21 08:00 YEARBOOK OF PAEDIATRIC ENDOCRINOLOGY 3
Thyroid
Valentina Chiavaroli
Valentina Chiavaroli
FC7.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Metabolic syndrome features in pre-pubertal children born after maternal pre-eclampsia
Valentina Chiavaroli
Valentina Chiavaroli
YI1.2
Sat 21 14:00 YOUNG INVESTIGATORS SESSION
The role of the gut microbiome in metabolism
Suna Kılınç
Suna Kılınç
FC7.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
Is the 1-hour post-load glucose level by 75g oral glucose tolerance test a new risk factor in predicting atherosclerosis?
Axel Dost
Axel Dost
FC7.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 7 - Diabetes and Insulin Session 2
2017 American Academy of Pediatrics Clinical Practice Guideline: impact on prevalence of arterial hypertension in children and adolescents with type 1 diabetes mellitus
Murat Karaoglan
Murat Karaoglan
RFC8.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Trade-off between olfactory bulb and eyeball volume in precocious puberty
Ana Canton
Ana Canton
RFC8.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Investigation of imprinting alterations in MKRN3 and DLK1 in a cohort of girls with central precocious puberty through specific DNA methylation analysis
Pavlos Fanis
Pavlos Fanis
RFC8.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Central precocious puberty caused by novel mutations in the promoter and 5′-UTR region of the imprinted MKRN3 gene
Alexsandra Malaquias
Alexsandra Malaquias
RFC8.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Evaluation of puberty in patients with Noonan syndrome and mutations in the RAS/MAPK genes
Leman Kotan
Leman Kotan
RFC8.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
CHD7 mutations in patients with anosmic or normosmic idiopathic hypogonadotropic hypogonadism
Maria Consolata Miletta
Maria Consolata Miletta
FC8.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Hypothalamic AgRP neurons drive endurance in food-restricted mice
Santiago Guerra-Cantera
Santiago Guerra-Cantera
FC8.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Analysis of hypothalamic metabolic circuits after normalization of body weight in mice that had been obese due to high fat diet intake
Santiago Guerra-Cantera
Santiago Guerra-Cantera
FC8.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Peripheral and hypothalamic alterations in the insulin like growth factor IGF system in response to high fat diet induced weight gain
Anna Rosenberg
Anna Rosenberg
FC8.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Absence of central adrenal insufficiency in adults with Prader-Willi syndrome
Alessandra Mancini
Alessandra Mancini
FC8.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
LGR4-Wnt β-catenin signalling directs GnRH network development, with defects leading to self-limited delayed puberty
Ahreum Kwon
Ahreum Kwon
FC8.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 8 - Pituitary, neuroendocrinology and puberty Session 1
Source and changes in serum level of kisspeptin in female rats at different developmental stages
Takeshi Yamaguchi
Takeshi Yamaguchi
RFC9.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Targeted next-generation sequencing for congenital hypothyroidism with positive neonatal TSH screening results
J Naafs
J Naafs
RFC9.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Age-specific reference values for plasma FT4 and TSH concentrations in healthy, term neonates at day three to seven, and 13 to 15 of life
Rossella Gaudino
Rossella Gaudino
RFC9.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Neonatal screening for congenital hypothyroidism analysis of a large cohort of affected patients 1987 2017 and relationship with perfluoroalkylated substances PFAs in north eastern Italy
Laura Bosch
Laura Bosch
RFC9.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Correlation between genotype and phenotype characteristics in children with congenital hyperinsulinism (CHI) in a specialist centre
Laura Lucaccioni
Laura Lucaccioni
RFC9.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Extra uterine growth restriction (EUGR) in very low birth weight infants: growth recovery and neurodevelopment by the corrected age of 2 years old
Preetha Purushothaman
Preetha Purushothaman
FC9.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Using CRISPR/Cas9 gene editing to study the molecular mechanisms of congenital hyperinsulinism (CHI)
Aashish Sethi
Aashish Sethi
FC9.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Heterozygous insulin receptor (INSR) mutation associated with neonatal hyperinsulinaemic hypoglycaemia and familial diabetes mellitus
Sandra Schulte
Sandra Schulte
FC9.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
Prenatal environment and genetic background influence urinary steroid excretion in monozygotic twins with intra-twin birth-weight differences
Susann Empting
Susann Empting
FC9.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 9 - Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
[18F]F-DOPA-PET/MRI or /CT in children with congenital hyperinsulinism
Doris Hebenstreit
Doris Hebenstreit
RFC10.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
Contemporary surgical approach in CAH 46XX – results from the I-DSD/I-CAH registries
Faruk Hadziselimovic
Faruk Hadziselimovic
RFC10.2
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
Cryptorchid boys with abrogated mini-puberty display differentially expressed genes involved in sudden infant death syndrome
Malika Alimussina
Malika Alimussina
RFC10.3
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
Level of uncertainty in diagnostic evaluation of boys with XY disorders of sex development (DSD)
Jakob Meinel
Jakob Meinel
RFC10.4
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
qPCR screening for Xp21.2 copy number variations in patients with elusive aetiology of 46,XY DSD
Odile Gaisl
Odile Gaisl
RFC10.5
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
Variants in NWD1 gene leading to different degrees of gonadal dysgenesis
Tikva Shore
Tikva Shore
RFC10.6
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
A mutation in the nucleoporin-107 gene causes aberrant Dpp/BMP signaling and XX gonadal dysgenesis
James Oakes
James Oakes
FC10.1
Fri 20 09:30 FREE COMMUNICATIONS & RAPID FREE COMMUNICATIONS 10 - Sex differentiation, gonads and gynaecology or sex endocrinology
Investigating the roles of androgens in male reproductive development, maintenance and function by characterisation of androgen and cortisol deficient 11ß-hydroxylase mutant zebrafish lines